Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment

Published:2024-09 Issue:5 Volume:19 Page:769-778
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Sho Takuya,Suda Goki^ORCID,Ohara Masatsugu,Kohya Risako,Sasaki Takashi,Yoshida Sonoe,Hosoda Shunichi,Ogawa Koji,Kitagataya Takashi,Maehara Osamu,Ohnishi Shunsuke,Kawagishi Naoki,Natsuizaka Mitsuteru,Nakai Masato,Baba Masaru,Yamamoto Yoshiya,Tsukuda Yoko,Meguro Takashi,Yamada Ren,Kobayashi Tomoe,Takagi Tomofumi,Sakamoto Naoya,

Funder

AMED

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11523-024-01092-7.pdf

Reference14 articles.

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet. 2003;362:1907–17. https://doi.org/10.1016/s0140-6736(03)14964-1.

2. Llovet JM, et al. Hepatocellular carcinoma. Nat Rev Dis Prime. 2021;7:6. https://doi.org/10.1038/s41572-020-00240-3.

3. Abou-Alfa, G. K. et al. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma. NEJM Evidence 1, EVIDoa2100070, https://doi.org/10.1056/EVIDoa2100070 (2022).

4. Finn RS, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382:1894–905. https://doi.org/10.1056/NEJMoa1915745.

5. Gordan, J. D. et al. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update. J Clin Oncol, JCO2302745, https://doi.org/10.1200/JCO.23.02745 (2024).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP